• Home
  • About
  • Clinical
  • Authors
  • Most read this year
  • GP Opinion
  • Videos & Podcasts
  • Professional
  • Comments policy
  • RACGP
  • poll
Menu

Filter
Expanded PBS listing for empagliflozin

Expanded PBS listing for empagliflozin

An RACGP expert describes the change as a ‘double win’, with the 1 April expansion to benefit more patients with type 2 diabetes.


Drug expanded on PBS for CKD treatment

Drug expanded on PBS for CKD treatment

GPs can now prescribe empagliflozin for eligible patients with chronic kidney disease, but should be aware of specific eligibility criteria.


GLP-1 RA prescribing checks flagged

GLP-1 RA prescribing checks flagged

GPs may soon need Services Australia approval prior to prescribing the diabetes medications, following evidence of ‘high use’ outside of PBS restrictions.


SGLT2 inhibitors for kidney and heart disease

SGLT2 inhibitors for kidney and heart disease

Normally used as a glucose-lowering agent in the treatment of type 2 diabetes, SGLT2 inhibitors have been found to have beneficial effects in patients with heart failure and kidney disease.


Can PPIs impact lung cancer treatment?

Can PPIs impact lung cancer treatment?

New research suggests a common medication used by up to 30% of cancer patients may adversely affect immune therapy treatment.


ACE-inhibitors, ARBs and COVID-19: What GPs need to know

ACE-inhibitors, ARBs and COVID-19: What GPs need to know

Some are considering the role of antihypertensives in the coronavirus pandemic, but experts warn against abruptly stopping these medications.


Popular hypertension drug linked with suicide

Popular hypertension drug linked with suicide

Angiotensin receptor blockers may be associated with a higher risk of suicide than alternative medications, a new study has found.


Evidence of PPI danger grows

Evidence of PPI danger grows

Extended use of common heartburn medication has been linked to potentially fatal cardiovascular disease, stomach cancer and chronic kidney disease.


RACGP newsGP ArticlesnewsGP

Terms and conditions | Privacy statement | RACGP | recruitGP | AJGP

© 2018 The Royal Australian College of General Practitioners (RACGP) ABN 34 000 223 807